Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Kirk Insider Profile
4 Followers
David Kirk, Finance Director at GW Pharma, holds 59.50K shares in GW Pharma (Ticker: GWPH). Most recently, David Kirk ― shares of GW Pharma on ― for an estimated value of ―.
David Kirk GW Pharma (GWPH)Finance Director
GW Pharma (GWPH)
Finance Director
Not Ranked
David Kirk has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
David Kirk does not currently own shares as a corporate insider.
A breakdown of David Kirk's holdings
Insider Roles
David Kirk does not currently hold a role as a corporate insider.
Roles that David Kirk holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by David Kirk
David Kirk's Trading History
List of latest transactions for each holding click on a transaction to see David Kirk's performance on stock
You May Also Like
David Kirk insider profile FAQ
What is the percentage of profitable transactions made by David Kirk?
The percentage of profitable transactions made by David Kirk is ―.
What is the average return per transaction made by David Kirk?
The average return per transaction made by David Kirk is ―.
What stocks does David Kirk hold?
David Kirk holds: GWPH stocks.
What was David Kirk’s latest transaction?
David Kirk latest transaction was an Uninformative Buy of ―.
What was David Kirk's most profitable transaction?
David Kirk’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is David Kirk's role in GW Pharma?
David Kirk's role in GW Pharma is Finance Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.